Acute Kidney Injury in Patients with Cirrhosis | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Description Cirrhosis is a major cause of morbidity and mortality in the United States and
worldwide. It consists of compensated, decompensated, and further decompensated stages; …

Results: One hundred and forty patients were enrolled (84% men, 59% alcohol-associated
disease, mean MELD-Na 25±SD 5.6). A median daily dose of infused terlipressin was 4.3 …

Patients with cirrhosis are prone to develop acute kidney injury (AKI), a complication
associated with a markedly increased in-hospital morbidity and mortality, along with a risk of …

DESIGN: Patients were randomly assigned in a 2: 1 ratio to receive terlipressin or placebo
for up to 14 days. SETTING: A retrospective analysis of data from the phase III CONFIRM …

Hepatorenal syndrome–acute kidney injury (HRS-AKI) occurs in the setting of advanced
chronic liver disease, portal hypertension, and ascites. HRS-AKI is found in∼ 20% of …

Background Hepatorenal syndrome (HRS) is characterized by severely reduced renal
perfusion that precipitates rapid morbidity and mortality. Terlipressin is the only US Food and …

Hepatorenal syndrome (HRS), defined by the extreme manifestation of renal impairment in
patients with cirrhosis, is characterized by reduced renal blood flow and glomerular filtration …

Objectives To describe how systematic reviews with network meta-analyses (NMAs) that
used the Grading of Recommendations Assessment, Development, and Evaluation …

Background Hepatorenal syndrome (HRS) bears a very poor prognosis with unmet need for
safe and effective therapies. This systematic review and meta-analysis aimed to re-assess …